HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,176,172 | -1.2% | 14,217 | +2.0% | 0.01% | 0.0% |
| Q1 2024 | $1,190,206 | -1.8% | 13,945 | -1.6% | 0.01% | -11.1% |
| Q4 2023 | $1,212,190 | -6.1% | 14,176 | -1.6% | 0.01% | -18.2% |
| Q3 2023 | $1,290,579 | +7.0% | 14,407 | +1.7% | 0.01% | +10.0% |
| Q2 2023 | $1,206,434 | -0.6% | 14,170 | -3.4% | 0.01% | -9.1% |
| Q1 2023 | $1,213,446 | +6.5% | 14,664 | +1.3% | 0.01% | 0.0% |
| Q4 2022 | $1,138,852 | +10.4% | 14,480 | +3.9% | 0.01% | 0.0% |
| Q3 2022 | $1,032,000 | +14.3% | 13,934 | +0.6% | 0.01% | +22.2% |
| Q2 2022 | $903,000 | +3.4% | 13,851 | +0.3% | 0.01% | +28.6% |
| Q1 2022 | $873,000 | +19.9% | 13,815 | +0.6% | 0.01% | +16.7% |
| Q4 2021 | $728,000 | -25.5% | 13,734 | -0.8% | 0.01% | -25.0% |
| Q3 2021 | $977,000 | +6.1% | 13,843 | +0.2% | 0.01% | +14.3% |
| Q2 2021 | $921,000 | -43.9% | 13,815 | -6.5% | 0.01% | -50.0% |
| Q1 2021 | $1,641,000 | -6.0% | 14,781 | +0.5% | 0.01% | -12.5% |
| Q4 2020 | $1,746,000 | +31.7% | 14,703 | -3.3% | 0.02% | +23.1% |
| Q3 2020 | $1,326,000 | +30.4% | 15,203 | +33.9% | 0.01% | -7.1% |
| Q2 2020 | $1,017,000 | -14.2% | 11,353 | -4.6% | 0.01% | -30.0% |
| Q1 2020 | $1,186,000 | -64.1% | 11,899 | -58.6% | 0.02% | -50.0% |
| Q4 2019 | $3,302,000 | -17.3% | 28,741 | -9.2% | 0.04% | -18.4% |
| Q3 2019 | $3,991,000 | -10.8% | 31,642 | -14.9% | 0.05% | -5.8% |
| Q2 2019 | $4,472,000 | +39.6% | 37,164 | +1.5% | 0.05% | +36.8% |
| Q1 2019 | $3,204,000 | -13.7% | 36,626 | -1.3% | 0.04% | -20.8% |
| Q4 2018 | $3,711,000 | -11.8% | 37,096 | +1.1% | 0.05% | +20.0% |
| Q3 2018 | $4,206,000 | +29.4% | 36,704 | +1.3% | 0.04% | +21.2% |
| Q2 2018 | $3,251,000 | -47.3% | 36,246 | -57.0% | 0.03% | -46.8% |
| Q1 2018 | $6,166,000 | +19.6% | 84,275 | -5.1% | 0.06% | +24.0% |
| Q4 2017 | $5,156,000 | +320.9% | 88,775 | +225.2% | 0.05% | +233.3% |
| Q3 2017 | $1,225,000 | +13.2% | 27,297 | -0.4% | 0.02% | 0.0% |
| Q2 2017 | $1,082,000 | -1.5% | 27,397 | +1.1% | 0.02% | 0.0% |
| Q1 2017 | $1,099,000 | +2.8% | 27,097 | +1.9% | 0.02% | -6.2% |
| Q4 2016 | $1,069,000 | +11.5% | 26,597 | +0.4% | 0.02% | +6.7% |
| Q3 2016 | $959,000 | +24.9% | 26,497 | 0.0% | 0.02% | +36.4% |
| Q2 2016 | $768,000 | -15.9% | 26,497 | +1.5% | 0.01% | -8.3% |
| Q1 2016 | $913,000 | +12.9% | 26,097 | +4.0% | 0.01% | +9.1% |
| Q4 2015 | $809,000 | +2.5% | 25,097 | +2.9% | 0.01% | 0.0% |
| Q3 2015 | $789,000 | -41.3% | 24,397 | -32.0% | 0.01% | -31.2% |
| Q4 2014 | $1,343,000 | +7.8% | 35,898 | +0.6% | 0.02% | +6.7% |
| Q3 2014 | $1,246,000 | -6.5% | 35,698 | -5.6% | 0.02% | -6.2% |
| Q2 2014 | $1,333,000 | +10.0% | 37,798 | +1.6% | 0.02% | +6.7% |
| Q1 2014 | $1,212,000 | -29.8% | 37,198 | -9.3% | 0.02% | -28.6% |
| Q4 2013 | $1,727,000 | -5.8% | 40,998 | -10.9% | 0.02% | -8.7% |
| Q3 2013 | $1,834,000 | -3.8% | 45,998 | -0.2% | 0.02% | -11.5% |
| Q2 2013 | $1,906,000 | -1.1% | 46,098 | -0.4% | 0.03% | -7.1% |
| Q1 2013 | $1,928,000 | – | 46,298 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |